Thousands of Americans suffer from Chronic Obstructive Pulmonary Disease (COPD), but new recommendations from a pair of health organizations may help ease their discomfort. Read More »

The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience Read More »

One of the fastest-growing pharmaceuticals companies in the country, headquartered in Lexington County, today announced several major expansion and investment projects. Read More »

A study facilitated by Vizient, Inc. and recently published in the Journal of American Medical Association Internal Medicine yielded new insights about patients with presumed penicillin allergies. Read More »

PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical as a limited distribution partner for new drug DOJOLVI™ (triheptanoin). DOJOLVI™ (a highly purified, pharmaceutical-grade, synthetic seven carbon fatty acid triglyceride) is a specially designed synthetic triglyceride compound, which was developed to treat patients with long-chain fatty acid oxidation disorders (LC-FAOD). Read More »

The National Association of Board of Pharmacy (NABP) is urging members of Congress to support federal programs to deal with the COVID-19 outbreak as well as an epidemic of opioid drug abuse in the country the virus might be fueling. Read More »

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced that Vu Truong, Ph.D., Chief Executive Officer, will participate in Cantor Fitzgerald's Virtual Symposium: "Winning Ways to Treat Infections and COVID-19" being held on Tuesday, June 30, 2020. Read More »

The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists appreciates the Food and Drug Administration's (FDA's) continuing efforts to review and advise the nation on the safe and effective use of hydroxychloroquine, chloroquine, and other medications to prevent and treat coronavirus. Read More »

Telehealth can be a new frontier for pharmacists, according to the incoming president of American Pharmacists Association, the association reported on its website. Read More »

Mylan achieves key milestone to provide U.S. multiple sclerosis patients with more affordable generic version of Biogen's Tecfidera® capsules Read More »

Kaiser Permanente to join as a governing member with the goal of helping to secure supplies of essential generic medications during COVID-19 and beyond Read More »

A bill introduced by U.S. Sen. Joni Ernst (R-IA) would give companies incentives if they brought their pharmaceutical, supply and medical device manufacturers back to the United States from China, the Ripon Advance reported. Read More »

Pharmacy Times, the leading publication for pharmacists in the nation, in an independent survey conducted with U.S. News & World Report has again named Prevagen the #1 pharmacist recommended memory support brand. Read More »

Nature Made® is once again the leading choice of pharmacists in nine key vitamin and supplement segments, according to a broad survey and ranking of top recommended health products released by U.S. News & World Report, in collaboration with Pharmacy Times. Nature Made is ranked as the #1 Pharmacist Recommended brand for:1 Read More »

Sourcing activity for pharmaceutical contract manufacturing has gone up 234% since last year and 220% since last quarter, ThomasNet reported. Read More »

The Centers for Disease Control and Prevention has updated its guidance on providing non-COVID-19 clinical care during the pandemic. Read More »

Gojji, a data-driven chronic care management company, has partnered with PerformRx, a URAC and NCQA-accredited full-service pharmacy benefit manager (PBM), to provide state- of-the-art chronic disease management products and best in class clinical services for their clients. Read More »

American Regent announces the introduction and availability of Estradiol Valerate Injection, USP – AO Rated and therapeutically equivalent to Delestrogen®1,2. Read More »

Under revised terms, AcelRx to acquire Tetraphase for $37.0 million in stock and cash plus CVRs Read More »

International reference pricing (IRP) for drugs is under consideration in the U.S. as health care experts are discussing an International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting to be held annually. Read More »